Seeing Is Believing
Currently out of the existing stock ratings of David Li, 3 are a HOLD (100%).
Analyst David Li, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 7.65% achieved within 135 days.
David Li’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Apr-2024.
Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 4/12/2023. The price target of $263.3 was fulfilled within 1 day with a profit of $8.42 (3.3%) receiving and performance score of 33.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$300
$123.5 (69.97%)
$319
21 days ago
(03-Dec-2024)
3/10 (30%)
$93.22 (45.08%)
126
Buy
$260
$83.5 (47.31%)
$254
1 months 11 days ago
(13-Nov-2024)
4/8 (50%)
$61.6 (31.05%)
125
Buy
$288
$111.5 (63.17%)
$285
4 months 16 days ago
(08-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
$164.3
$-12.2 (-6.91%)
$212
8 months 16 days ago
(08-Apr-2024)
3/3 (100%)
$14.55 (9.72%)
135
Buy
$345
$168.5 (95.47%)
$350
9 months 27 days ago
(27-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
What Year was the first public recommendation made by David Li?